Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,705.20
+9.20 (0.54%)
Jun 1, 2026, 3:30 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 321.54 billion as of June 1, 2026. Its market cap has increased by 68.42% in one year.
Market Cap
321.54B
Enterprise Value
335.55B
Revenue
92.04B
Ranking
n/a
PE Ratio
34.78
Stock Price
1,705.20
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 321.54B, an increase of 25.14%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 321.54B | 24.31% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 657.37B |
| Glenmark Pharmaceuticals | 641.98B |
| Ipca Laboratories | 386.75B |
| Gland Pharma | 370.70B |
| Ajanta Pharma | 365.78B |
| Wockhardt | 330.09B |
| Piramal Pharma | 229.44B |
| Eris Lifesciences | 193.86B |